HOME >> BIOLOGY >> NEWS
Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show

(PHILADELPHIA) Scientists at the Center for Translational Medicine at Thomas Jefferson University in Philadelphia have staved off heart failure in animals by using gene therapy to shut down the adrenal glands excessive output of fight or flight hormones such as epinephrine and norepinephrine. By blocking GRK2, an important regulatory enzyme, they cut the hormone production that forces the heart to pump too hard, leading to heart failure. Such a novel approach targeting the adrenal gland in addition to the heart provides a potential new strategy against heart failure, and could lead to a new class of drugs.

The researchers, led by Walter Koch, Ph.D., W.W. Smith Professor of Medicine and director of the Center for Translational Medicine in the Department of Medicine at Jefferson Medical College, report their findings February 18, 2007, in an advance online publication in the journal Nature Medicine.

The emphasis has always been in treating right at the heart, says Stephen B. Liggett, M.D., director of the cardiopulmonary genomics program at the University of Maryland School of Medicine, who has written an accompanying editorial. Despite our best efforts, about half of all heart failure patients die within five years of diagnosis, so clearly something new is needed. These results add a completely new dimension to the way physicians might be able to intervene to improve heart failure therapy. When an individuals heart begins to fail, the sympathetic nervous system, attempting to compensate for the weakened heart, goes into overdrive, pumping out increasing levels of stimulants catecholamines such as epinephrine and norepinephrine, making a bad situation worse. The typical treatment beta blockers inhibit the beta adrenergic receptors on the heart, blocking the hormones that force the heart to work overtime.

Dr. Kochs group focused instead on the source of catecholamines the adrenal gland. It discovered that in heart failure,
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
18-Feb-2007


Page: 1 2

Related biology news :

1. Targeting key proteins of carcinogenesis
2. Targeting tumors the natural way
3. Targeting tau: Inflammation study suggests new approach for fighting Alzheimers
4. Best of both worlds -- Targeting a single gene could inhibit bone decay and stimulate bone growth
5. Targeting wolbachia, doxycycline reduces pathology of lymphatic filariasis
6. Targeting lung cancer
7. Targeting the dosage compensation complex
8. Targeting pancreatic cancer
9. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
10. Targeting tumor growth
11. How the adrenal clock keeps the body in synch

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2019)... ... July 23, 2019 , ... NanoFUSE is ... biologic strip indicated for spine and orthopedic use. Bioactive glass is a calcium ... has been clinically-proven in orthopedics for over 30 years and now NanoFUSE Biologics ...
(Date:7/19/2019)... ... 19, 2019 , ... Improved Pharma LLC announces the upcoming ... Synchrotron X-ray Pair Distribution (SXPDF) Studies”. The authors are Stephen R. Byrn and ... Laboratory and Gabriel de Araujo of the University of Sao Paulo. ...
(Date:7/17/2019)... ... July 15, 2019 , ... RCH Solutions ... Sciences and Healthcare companies, announces the availability of new specialty advisory practice, a ... to start-up and emerging bio-pharma companies interested in achieving specific outcomes related to ...
Breaking Biology News(10 mins):
(Date:8/8/2019)... ... 08, 2019 , ... Inference Solutions , a global ... announced that the company’s Studio Intelligent Virtual Agent (IVA) platform earned Frost ... officially accept the award at Frost & Sullivan’s annual Excellence in Best Practices ...
(Date:8/6/2019)... (PRWEB) , ... August 06, 2019 , ... ... Radio (LSMR) have joined forces in launching the biweekly SDBN BUZZ podcast focused ... growth. SDBN BUZZ podcast will also serve to promote the region and attract ...
(Date:8/6/2019)... ... August 05, 2019 , ... ... has been recognized as a distinguished leader by PharmaVOICE magazine, earning him a ... article in the magazine’s July/August special issue. , As the executive vice president ...
(Date:8/4/2019)... , ... August 02, 2019 , ... Cirtec Medical Corporation, ... devices, today announced that it has begun construction on a 30,000 sq. ft. ... miles from San Jose. , The facility, which is expected to be fully ...
Breaking Biology Technology:
Cached News: